Alan Goforth is a freelance writer in suburban Kansas City. In addition to freelancing for several publications, he has written a dozen books about sports and other topics.
All the manufacturers of the first 10 prescription drugs selected for Medicare price negotiations agreed to participate by the Oct. 1 deadline, however, the process could be complicated by lawsuits filed by all of these drugmakers.
The agreements settle whistleblower lawsuits that the Department of Justice joined, alleging the insurer submitted false diagnosis codes to artificially inflate its payments from the Medicare Advantage program.
Six in 10 clinicians believe AI can help with decision-making, however, 55% said it is not yet ready for medical use, and for those with 16-plus years of experience, the skepticism level was even higher, says a new survey.
The Senate Finance Committee, which has jurisdiction over Medicare, introduced a bipartisan bill on Thursday – the latest move by Congress to rein in pharmacy benefit managers by creating independent audit efforts.
Merck, AstraZeneca, Bristol Myers Squibb and Boehringer Ingelheim have signed agreements to participate in the first round of Medicare drug price negotiations, while the remaining drugmakers have until Oct. 1 to decide.
While Republican presidential candidate Nikki Haley wants to raise the retirement age of younger Americans to prevent Social Security funds from running out, more than half of them say it should be lowered, says a new survey.